Market Research Logo

Alopecia Market Size, Share & Trends Analysis Report By Disease Type (Alopecia Areata, Androgenetic Alopecia), By End Use, By Sales Channel, By Gender, By Region, And Segment Forecasts, 2019 - 2025

Alopecia Market Size, Share & Trends Analysis Report By Disease Type (Alopecia Areata, Androgenetic Alopecia), By End Use, By Sales Channel, By Gender, By Region, And Segment Forecasts, 2019 - 2025

The global alopecia market size is anticipated to reach USD 12.37 billion by 2025, according to a report published by Grand View Research, Inc. It is expected to expand at a CAGR of 5.5% during the forecast period. Technological advancements, growing disease prevalence, and environmental pollution, and increase in per-capita healthcare expenditures across the globe are anticipated to propel the growth.

Factors such as new product launches and technological advancements are also impacting the market dynamics. For instance, Hairmax Laser comb, Follinex Massager Comb, Lifemax Infrared Hair Brush, and hair growth renewing lasers are some of the products built on advanced technology. Also, the launch of new drugs is improving the treatment success rate and clinical outcomes.

Based on condition, the market is classified into alopecia areata, androgenetic alopecia, and others. Androgenetic alopecia segment led the market in 2018 with revenue of USD 7,242.7 million and is anticipated to grow at a lucrative CAGR over the forecast period. Factors responsible for high revenue of this segment include availability of various treatments such as topical treatments and oral treatments involving the use of minoxidil and finasteride and surgical treatments like hair transplantation and replacement. On the other hand, alopecia areata is anticipated to expand at the fastest CAGR of 6.3% over the forecast period.

On the basis of end use, the alopecia market is segmented into homecare settings and dermatology clinics. Dermatology clinics led the market in 2018 with a revenue of USD 4,696.4 million, due to the presence of a large number of dermatology clinics with new technologies and high adoption of prescription hair care products. Homecare settings segment is anticipated to register the fastest CAGR of 6.0% during the forecast period. Increasing availability of many new OTC medications and products along with increasing preference for convenience and ease of use are some of the factors responsible for this growth.

North America led the market in 2018 and is anticipated to expand at a lucrative rate over the forecast period. Factors attributed to this high revenue are high prevalence of autoimmune disorders such as Polycystic Ovary Syndrome (PCOS) and cancer. Moreover, presence of advanced healthcare infrastructure, high disposable income, and novel therapeutic options are anticipated to further fuel the growth. Asia Pacific is anticipated to grow at the fastest rate over the forecast period owing to increasing awareness regarding available treatment options for alopecia and increasing per capital healthcare expenditure in emerging countries such as China and India.

Some of the key companies operating in the alopecia market are Cipla Inc.; Sun Pharmaceutical Industries Ltd.; Johnson and Johnson AG; Merck & Co., Inc.; and Lexington International LLC, Cirrus Hair Centers, Vita-Cos-Med Klett-Loch GmbH; Transitions Hair Pty Ltd., Follica, Inc. and Capillus.

Further key findings from the report suggest:

  • Androgenetic alopecia segment led the market in 2018 with revenue of USD 7,242.7 million, owing to increasing prevalence of androgenetic alopecia and growing awareness regarding the availability of treatments
  • Homecare settings is expected to witness the fastest CAGR of 6.0% over the forecast period owing to increasing preference for convenience and ease of use along with increasing availability of OTC medication
  • Asia Pacific is expected to witness the fastest CAGR owing to the high population base, increasing availability of treatment options, and growing per capita healthcare expenditure
  • Some of the key players in the alopecia market are Cipla Inc.; Sun Pharmaceutical Industries Ltd.; Johnson and Johnson AG; Merck & Co., Inc.; and Lexington International LLC, Cirrus Hair Centers, Vita-Cos-Med Klett-Loch GmbH; Transitions Hair Pty Ltd., Follica, Inc. and Capillus.
Please note The report will be updated with the latest data and delivered to you within 3-4 business days.


Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR's Internal Database
1.3.3 Secondary Sources & Third Party perspectives
1.3.4 Primary Research
1.4 Information Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
Chapter 2 Executive Summary
2.1 Alopecia Market Outlook, By Revenue (USD Million)
2.2 Alopecia Segment Outlook, By Revenue (USD Million)
2.3 Competititve Insights
Chapter 3 Alopecia Market Variables, Trends and Scope
3.1 Penetration & Growth Prospect Mapping
3.2 Product Pipeline Analysis, by Stage
3.3 Industry Value Chain Analysis
3.3.1 User Perspective Analysis
3.3.1.1 Consumer behaviour analysis
3.3.1.2 Market influencer analysis
3.3.2 Cost structure analysis
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Increasing prevalance of alopecia
3.4.1.2 Increasing prevalence of healthcare expensitures
3.4.1.3 Increasing prevalence of chronic diseases
3.4.1.3.1 PCOS
3.4.1.3.2 Cancer
3.4.1.3.3 Rheumatoid Arthritis
3.4.1.4 Technological advancements in alopecia treatment
3.4.2 Market restraint analysis
3.4.2.1 Lack of reimbursement policies for alopecia treatment
3.4.3 Industry challenges
3.5 Alopecia Market Analysis Tools
3.5.1 Industry analysis - Porter's
3.5.1.1 Supplier power
3.5.1.2 Buyer power
3.5.1.3 Substitution threat
3.5.1.4 New entrants threat
3.5.1.5 Competitive rivalry
3.5.2 PESTEL Analysis
3.5.2.1 Political landscape
3.5.2.2 Economic landscape
3.5.2.3 Social landscape
3.5.2.4 Technology landscape
3.5.3 Major deals and strategic alliances analysis
3.5.4 Market entry strategies
Chapter 4 Alopecia Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization
4.3 Public Companies
4.3.1 Company Market Position Analysis
4.3.2 Company Market Share/Ranking, by Region
4.4 Private Companies
4.4.1 List of Key Emerging Companies/Technology Disruptors/Innovators
4.4.2 Regional Network Map
4.4.3 Company Market Position Analysis
4.4.4 Supplier Ranking
Chapter 5 Alopecia Market: Disease Type Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Alopecia Market Share by Disease Type, 2018 & 2025
5.3 Segment Dashboard
5.4 Alopecia Areata
5.4.1 Alopecia areata market estimates and forecasts, 2014 - 2025 (USD Million)
5.4.2 Alopecia areata market estimates and forecasts, by gender, 2014 - 2025 (USD Million)
5.5 Androgenetic Alopecia
5.5.1 Androgenetic alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
5.5.2 Androgentic alopecia market estimates and forecasts, by gender, 2014 - 2025 (USD Million)
5.6 Others
5.6.1 Other alopecia diseases market estimates and forecasts, 2014 - 2025 (USD Million)
5.6.2 Other alopecia diseases market estimates and forecasts, 2014 - 2025, by gender (USD Million)
Chapter 6 Alopecia Market: End Use Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 Alopecia Market Share by End Use, 2018 & 2025
6.3 Segment Dashboard
6.4 Homecare Settings
6.4.1 Homecare settings market estimates and forecasts, 2014 - 2025 (USD Million)
6.5 Dermatology Clinics
6.5.1 Dermatology clinics market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 7 Alopecia Market: Sales Channel Estimates & Trend Analysis
7.1 Definitions & Scope
7.2 Alopecia Market Share by Sales channel, 2018 & 2025
7.3 Segment Dashboard
7.4 Prescriptions
7.4.1 Prescriptions market estimates and forecasts, 2014 - 2025 (USD Million)
7.5 OTC
7.5.1 OTC market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 8 Alopecia Market: Gender Estimates & Trend Analysis
8.1 Definitions & Scope
8.2 Alopecia Market Share by Gender, 2018 & 2025
8.3 Segment Dashboard
8.4 Male
8.4.1 Male alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
8.5 Female
8.5.1 Female alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 9 Alopecia Market: Regional Estimates & Trend Analysis, by Product
9.1 Regional Market Snapshot
9.2 Regional Market Share and Leading Players, 2018
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa
9.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacifc
9.3.4 Latin America
9.4.5 Middle East & Africa
9.4 Market Size, & Forecasts, and Trend Analysis, 2018 to 2025:
9.4.1 North America
9.4.1.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.1.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.1.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.1.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.1.5 U.S.
9.4.1.5.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.1.5.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.1.5.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.1.5.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.1.6 Canada
9.4.1.6.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.1.6.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.1.6.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.1.6.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.2 Europe
9.4.2.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.2.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.2.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.2.3.1 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.2.4 U.K.
9.4.2.4.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.2.4.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.2.4.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.1.4.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.2.5 Germany
9.4.2.5.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.2.5.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.2.5.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.1.4.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.2.6 Spain
9.4.2.6.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.2.6.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.2.6.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.1.4.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.2.7 France
9.4.2.7.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.2.7.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.2.7.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.1.4.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.2.8 Italy
9.4.2.8.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.2.8.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.2.8.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.1.4.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.2.9 Russia
9.4.2.9.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.2.9.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.2.9.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.1.4.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.3 Asia Pacific
9.4.3.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.3.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.3.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.3.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.3.5 China
9.4.3.5.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.3.5.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.3.5.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.3.5.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.3.6 Japan
9.4.3.6.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.3.6.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.3.6.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.3.6.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.3.7 India
9.4.3.7.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.3.7.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.3.7.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.3.7.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.3.8 South Korea
9.4.3.8.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.3.8.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.3.8.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.3.8.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.3.9 Singapore
9.4.3.9.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.3.9.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.3.9.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.3.9.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.3.10 Australia
9.4.3.10.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.3.10.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.3.10.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.3.10.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.4 Latin America
9.4.4.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.4.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.4.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.4.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.4.5 Brazil
9.4.4.5.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.4.5.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.4.5.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.4.5.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.4.6 Mexico
9.4.4.6.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.4.6.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.4.6.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.4.6.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.4.7 Argentina
9.4.4.7.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.4.7.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.4.7.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.4.7.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.5 Middle East & Africa (MEA)
9.4.5.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.5.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.5.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.5.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.5.5 South Africa
9.4.5.5.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.5.5.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.5.5.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.5.5.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.5.6 Saudi Arabia
9.4.5.6.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.5.6.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
9.4.5.6.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.5.6.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
9.4.5.7 UAE
9.4.5.7.1 Market estimates and forecasts, by disease type 2014 - 2025 (USD Million)
9.4.5.7.2 Market estimates and forecasts, by End use 2014 - 2025 (USD Million)
9.4.5.7.3 Market estimates and forecasts, by sales channel 2014 - 2025 (USD Million)
9.4.5.7.4 Market estimates and forecasts, by gender 2014 - 2025 (USD Million)
Chapter 10 Competitive Landscape
10.1 Company Profiles
10.1.1 Cipla, Inc.
10.1.1.1 Company Overview
10.1.1.2 Financial Performance
10.1.1.3 Product Benchmarking
10.1.1.4 Strategic Initiatives
10.1.2 Sun Pharmaceuticals Industries Ltd.
10.1.2.1 Company Overview
10.1.2.2 Financial Performance
10.1.2.3 Product Benchmarking
10.1.2.4 Strategic Initiatives
10.1.3 Johnson & Johnson Services, Inc.
10.1.3.1 Company Overview
10.1.3.2 Financial Performance
10.1.3.3 Product Benchmarking
10.1.3.3 Strategic Initiatives
10.1.4 Merck & Co., Inc.
10.1.4.1 Company Overview
10.1.4.2 Financial Performance
10.1.4.3 Product Benchmarking
10.1.4.4 Strategic Initiatives
10.1.5 Lexington International LLC
10.1.5.1 Company Overview
10.1.5.2 Financial Performance
10.1.5.3 Product Benchmarking
10.1.5.4 Strategic Initiatives
10.1.6 Cirrus Hair Centers
10.1.6.1 Company Overview
10.1.6.2 Financial Performance
10.1.6.3 Product Benchmarking
10.1.6.4 Strategic Initiatives
10.1.7 Vita-Cos-Med Klett-Loch GmbH
10.1.7.1 Company Overview
10.1.7.2 Financial Performance
10.1.7.3 Product Benchmarking
10.1.7.4 Strategic Initiatives
10.1.8 Transitions Hair Pty Ltd.
10.1.8.1 Company Overview
10.1.8.2 Financial Performance
10.1.8.3 Product Benchmarking
10.1.8.4 Strategic Initiatives
10.1.9 Follica, Inc.
10.1.9.1 Company Overview
10.1.9.2 Financial Performance
10.1.9.3 Product Benchmarking
10.1.9.4 Strategic Initiatives
10.1.10 Capillus
10.1.10.1 Company Overview
10.1.10.2 Financial Performance
10.1.10.3 Product Benchmarking
10.1.10.4 Strategic Initiatives
10.2 List of Other Manufacturers
List of Tables
Table 1 List of key emerging companies/technology disruptors/innovators
Table 2 Alopecia areata market estimates and forecasts, by gender, 2014 - 2025 (USD Million)
Table 3 Androgenetic alopecia market estimates and forecasts, by gender, 2014 - 2025 (USD Million)
Table 4 Other alopecia diseases market estimates and forecasts, by gender, 2014 - 2025 (USD Million)
Table 5 North America Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 6 North America Alopecia market, by End use 2014 - 2025 (USD Million)
Table 7 North America Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 8 North America Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 9 U.S. Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 10 U.S. Alopecia market, by End use 2014 - 2025 (USD Million)
Table 11 U.S. Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 12 U.S. Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 13 Canada Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 14 Canada Alopecia market, by End use 2014 - 2025 (USD Million)
Table 15 Canada Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 16 Canada Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 17 Europe Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 18 Europe Alopecia market, by End use 2014 - 2025 (USD Million)
Table 19 Europe Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 20 Europe Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 21 U.K. Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 22 U.K. Alopecia market, by End use 2014 - 2025 (USD Million)
Table 23 U.K. Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 24 U.K. Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 25 Germany Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 26 Germany Alopecia market, by End use 2014 - 2025 (USD Million)
Table 27 Germany Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 28 Germany Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 29 Spain Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 30 Spain Alopecia market, by End use 2014 - 2025 (USD Million)
Table 31 Spain Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 32 Spain Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 33 France Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 34 France Alopecia market, by End use 2014 - 2025 (USD Million)
Table 35 France Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 36 France Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 37 Italy Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 38 Italy Alopecia market, by End use 2014 - 2025 (USD Million)
Table 39 Italy Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 40 Italy Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 41 Russia Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 42 Russia Alopecia market, by End use 2014 - 2025 (USD Million)
Table 43 Russia Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 44 Russia Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 45 Asia Pacific Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 46 Asia Pacific Alopecia market, by End use 2014 - 2025 (USD Million)
Table 47 Asia Pacific Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 48 Asia Pacific Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 49 Japan Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 50 Japan Alopecia market, by End use 2014 - 2025 (USD Million)
Table 51 Japan Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 52 Japan Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 53 China Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 54 China Alopecia market, by End use 2014 - 2025 (USD Million)
Table 55 China Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 56 China Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 57 India Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 58 India Alopecia market, by End use 2014 - 2025 (USD Million)
Table 59 India Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 60 India Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 61 South Korea Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 62 South Korea Alopecia market, by End use 2014 - 2025 (USD Million)
Table 63 South Korea Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 64 South Korea Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 65 Singapore Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 66 Singapore Alopecia market, by End use 2014 - 2025 (USD Million)
Table 67 Singapore Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 68 Singapore Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 69 Australia Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 70 Australia Alopecia market, by End use2014 - 2025 (USD Million)
Table 71 Australia Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 72 Australia Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 73 Latin America Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 74 Latin America Alopecia market, by End use 2014 - 2025 (USD Million)
Table 75 Latin America Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 76 Latin America Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 77 Brazil Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 78 Brazil Alopecia market, by End use 2014 - 2025 (USD Million)
Table 79 Brazil Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 80 Brazil Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 81 Mexico Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 82 Mexico Alopecia market, by End use 2014 - 2025 (USD Million)
Table 83 Mexico Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 84 Mexico Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 85 Argentina Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 86 Argentina Alopecia market, by End use 2014 - 2025 (USD Million)
Table 87 Argentina Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 88 Argentina Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 89 MEA Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 90 MEA Alopecia market, by End use 2014 - 2025 (USD Million)
Table 91 MEA Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 92 MEA Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 93 South Africa Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 94 South Africa Alopecia market, by End use 2014 - 2025 (USD Million)
Table 95 South Africa Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 96 South Africa Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 97 Saudi Arabia Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 98 Saudi Arabia Alopecia market, by End use 2014 - 2025 (USD Million)
Table 99 Saudi Arabia Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 100 Saudi Arabia Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 101 UAE Alopecia market, by Disease Type 2014 - 2025 (USD Million)
Table 102 UAE Alopecia market, by End use 2014 - 2025 (USD Million)
Table 103 UAE Alopecia market, by Sales channel 2014 - 2025 (USD Million)
Table 104 UAE Alopecia market, by Gender 2014 - 2025 (USD Million)
Table 105 List of other market players
List of Figures
FIG. 1 Market research process
FIG. 2 Data Triangulation Techniques
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Market Snapshot
FIG. 9 Alopecia market variables, trends & scope
FIG. 10 Penetration & Growth Prospect Mapping
FIG. 11 Technology Timeline (Transition / various technology adoption past & future predictions)
FIG. 12 Market driver relevance analysis (Current & future impact)
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Company/Competition Categorization
FIG. 15 Key company market share analysis, 2018
FIG. 16 Company market position analysis (Public companies)
FIG. 17 Company Market Share/Ranking, by region
FIG. 18 Market Differentiators
FIG. 19 Company market position analysis (Private companies)
FIG. 20 Disease type market share analysis, 2018 & 2025
FIG. 21 Segment Dashboard
FIG. 22 Alopecia areata market revenue estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 23 Androgenetic alopecia market revenue estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 24 Other alopecia diseases market revenue estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 25 End use market share analysis, 2018 & 2025
FIG. 26 Segment Dashboard
FIG. 27 Homecare settings market revenue estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 28 Dermatology Clinics market revenue estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 30 Sales channel market share analysis, 2018 & 2025
FIG. 31 Segment Dashboard
FIG. 32 Prescriptions market revenue estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 33 OTC market revenue estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 34 Gender market share analysis, 2018 & 2025
FIG. 35 Segment Dashboard
FIG. 36 Male market revenue estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 37 Female market revenue estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 38 Regional market snapshot
FIG. 39 Regional outlook, 2018 & 2025
FIG. 40 North America alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 41 U.S. alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 42 Canada alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 43 Europe alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 44 Germany alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 45 U.K. alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 46 Spain alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 47 France alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 48 Italy alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 49 Russia alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 50 Asia Pacific alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 51 Japan alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 52 China alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 53 India alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 54 South Korea alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 55 Singapore alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 56 Australia alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 57 Latin America alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 58 Brazil alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 59 Mexico alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 60 Argentina alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 61 MEA alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 62 South Africa alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 63 Saudi Arabia alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 64 UAE alopecia market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 65 Strategy framework

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report